Evofem Biosciences Q1 EPS $(0.04), Sales $899.000K Up From $845.000K YoY

Benzinga Newsdesk www.benzinga.com Negative 80.8%

Neg 80.8% Neu 0% Pos 0%

Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.04) per share. The company reported $899.000 thousand in sales this quarter. This is a 6.39 percent increase over sales of $845.000 thousand the same period last year.